2020
DOI: 10.1155/2020/4683573
|View full text |Cite
|
Sign up to set email alerts
|

Changes in the Rhythm of Speech Difference between People with Nondegenerative Mild Cognitive Impairment and with Preclinical Dementia

Abstract: This study explores several speech parameters related to mild cognitive impairment, as well as those that might be flagging the presence of an underlying neurodegenerative process. Speech is an excellent biomarker because it is not invasive and, what is more, its analysis is rapid and economical. Our aim has been to ascertain whether the typical speech patterns of people with Alzheimer’s disease are also present during the disorder’s preclinical stages. To do so, we shall be using a task that involves reading … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
26
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(29 citation statements)
references
References 42 publications
3
26
0
Order By: Relevance
“…The analysis of disfluencies revealed the largest differences between the groups, and we found that the healthy controls tended to use fewer silent pauses, shorter maximum pause lengths and fewer disfluencies in total compared to the cognitively impaired groups. This result is in line with previous research showing that disfluencies are more common in discourse produced by persons with early MCI (Mueller et al, 2018 ) and in persons with a clinical diagnosis of MCI (Fleming, 2014 ; Szatloczki et al, 2015 ; Meilán et al, 2020 ).…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…The analysis of disfluencies revealed the largest differences between the groups, and we found that the healthy controls tended to use fewer silent pauses, shorter maximum pause lengths and fewer disfluencies in total compared to the cognitively impaired groups. This result is in line with previous research showing that disfluencies are more common in discourse produced by persons with early MCI (Mueller et al, 2018 ) and in persons with a clinical diagnosis of MCI (Fleming, 2014 ; Szatloczki et al, 2015 ; Meilán et al, 2020 ).…”
Section: Discussionsupporting
confidence: 92%
“…In that sense it should be noted that disfluencies are not solely indicative of word finding difficulties: individual differences may be related to verbal intelligence and working memory for example (Engelhardt et al, 2019 ). Persons with MCI tend to produce longer hesitations (Szatloczki et al, 2015 ), more pauses (Meilán et al, 2020 ) and have a lower speech rate (Szatloczki et al, 2015 ; Meilán et al, 2020 ). Although it is often concluded that disfluencies are early signs of cognitive decline, Mueller et al ( 2016 ) found no difference in disfluencies between participants judged as having preclinical (early) MCI and participants who were cognitively healthy.…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, Beltrami et al ( 2018 ) have found features that characterize different types of MCI, with differences between amnestic MCI and multidomain MCI in rhythmic features such as the pairwise variability index, and especially in acoustic features such as the duration of silence and speech segments, phonation rate, pause rate, and spectral centroid. In a recent study, Meilán et al ( 2020 ) have sought to find two different profiles within people with MCI and hypothesized that several features differentiate between people that will develop AD and people that will not deteriorate further.…”
Section: Resultsmentioning
confidence: 99%
“…MCI is an etiologically heterogenous entity and about 15-20% of patients with MCI go on to develop clinical Alzheimer disease (AD) (Jessen et al, 2010). Neuropsychological testing has been the main biomarker used to distinguish patients with MCI, who eventually develop AD, from those with MCI who do not (Mueller et al, 2018;Meilan et al, 2020). Like other non-invasive neuroimaging modalities, fNIRS has been explored as a potential biomarker to differentiate MCI and AD (Hong and Yaqub, 2019).…”
Section: Mild Cognitive Impairmentmentioning
confidence: 99%